Why Genfit Stock Is Skyrocketing Today
Investors applauded the company's latest clinical results.
GENFIT SPON ADS EACH REP 1 ORD SHS(GNFT)
Nasdaq Global Select
GNFT
$4.31
-$0.11
-2.5%
Price as of April 16, 2021, 8:00 p.m. EDT
View Interactive GNFT Charts
GENFIT SPON ADS EACH REP 1 ORD SHS
Interactive Chart
News & Analysis: GENFIT SPON ADS EACH REP 1 ORD SHS
Why Genfit Is Cratering Today
One of the company's pipeline candidates flopped in a late-stage clinical trial.
Better Buy: Intercept Pharmaceuticals or Genfit?
Both companies aim to grab a piece of the multi-billion dollar market for treating patients with the liver disease NASH. So, which one should you buy?
Can This NASH Stock Really Double Your Money?
An investment bank analyst thinks this biotech stock is worth more than twice its recent price.
3 Top Small-Cap Biotech Stocks for Aggressive Investors
They're risky, but these up-and-coming biotechs could be tremendous winners for investors willing to take on those risks.
3 Top Stocks That Aren't on Wall Street's Radar
Genfit, Changyou, and Children's Place aren't turning heads on Wall Street quite yet, but that could change very soon.
